| CAS NO: | 53587-29-4 |
| 包装 | 价格(元) |
| 250mg | 电议 |
| 500mg | 电议 |
| 1 g | 电议 |
| Cas No. | 53587-29-4 |
| 别名 | 左旋多巴D3 |
| Canonical SMILES | OC1=C([2H])C(C[C@H](N)C(O)=O)=C([2H])C([2H])=C1O |
| 分子式 | C9H8D3NO4 |
| 分子量 | 200.2 |
| 溶解度 | Water: sparingly soluble |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | L-DOPA-d3is intended for use as an internal standard for the quantification of L-DOPA by GC- or LC-MS. L-DOPA is a metabolic precursor of dopamine that is capable of crossing the blood-brain barrier.1It is produced from L-tyrosine by tyrosine hydroxylase and metabolized by catechol-O-methyl transferase (COMT). In the brain L-DOPA is converted to dopamine. Formulations containing L-DOPA have been used to increase dopamine concentrations in the brain as a treatment for Parkinson's disease and stroke recovery. 1.Berends, H.I., Nijlant, J.M.M., Movig, K.L.L., et al.The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic reviewEur. J. Phys. Rehabil. Med.45(4)621-630(2009) |
m.cnreagent.com